Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564275 · ClinicalTrials.gov registry record · NA
Proton Boost in Prostate Cancer
A NA study of Cancer of the Prostate, sponsored by University of Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03564275 is a NA study of Cancer of the Prostate that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 10 participants, below the 4,932-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03564275, a NA study of Cancer of the Prostate, is active but no longer recruiting, sponsored by University of Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation therapy (IMRT) produces decreased toxicity as compared to conventional photon IMRT alone in the treatment of prostate cancer. Our secondary objective is to determine the effectiveness of this treatment regimen. Effectiveness will be determined by length of time to progression or recurrence of disease and overall survival. Patients on this study will be treated with a course of photon radiation therapy followed by a boost course of proton radiation.
Conditions Studied
Interventions
- RADIATION Proton Boost
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2033-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564275
The ClinicalTrials.gov registry entry for NCT03564275 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,932-participant average among 11 other Cancer of the Prostate trials with a reported enrollment target (100% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer of the Prostate appearing as the primary indexed condition, and to 1 intervention - of which Proton Boost is the first listed.
NCT03564275 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03564275 about?
NCT03564275 is a clinical study titled "Proton Boost in Prostate Cancer". This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation therapy (IMRT) produces decreased toxicity as compared to conventional photon IMRT alone in the treatme...
What is the current status of trial NCT03564275?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-04-16. Estimated completion is 2033-04.
What conditions does trial NCT03564275 study?
This clinical trial studies the following conditions: Cancer of the Prostate.
What interventions are being tested in trial NCT03564275?
The interventions under investigation include: Proton Boost (RADIATION).
Who is sponsoring clinical trial NCT03564275?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03564275 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of the Prostate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of Impact of AI on Prostate Cancer Workflow
RECRUITING · NA
-
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
RECRUITING · NA
-
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
COMPLETED · NA
-
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
RECRUITING
-
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.